Observational studyJapanese journal of ophthalmology2025

First-year real-world experience of intravitreal brolucizumab injection for refractory neovascular age-related macular degeneration.

Jeong Hyun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.